ORASURE TECHNOLOGIES, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ORASURE TECHNOLOGIES, INC (OSUR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.39 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-09
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-12-31 was 0.00 shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 0.00 shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-06-30 was 0.00 shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-03-31 was 589.00K shares, a 133.73% increase year-over-year.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.39M shares, a 134.12% increase from fiscal 2024.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 595.00K shares, a 3.57% decline from fiscal 2023.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 617.00K shares, a 4.75% increase from fiscal 2022.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 589.00K shares, a 60.93% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.39M shares 10-K · filed 2026-03-09 | |||
| 2024-12-31 | 595.00K shares 10-K · filed 2025-03-07 | |||
| 2023-12-31 | 617.00K shares 10-K · filed 2024-03-11 | |||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-03 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-03 | 589.00K shares 10-K · filed 2023-03-03 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-08 | 589.00K shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 589.00K shares 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | 589.00K shares 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 366.00K shares 10-K · filed 2022-03-01 | |||
| 2021-03-31 | 252.00K shares 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 510.00K shares 10-K · filed 2021-03-01 | |||
| 2020-03-31 | 510.00K shares 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | 215.00K shares 10-K · filed 2020-03-02 | |||
| 2019-03-31 | 204.00K shares 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 171.00K shares 10-K · filed 2019-02-28 | |||
| 2018-03-31 | 122.00K shares 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | 231.00K shares 10-K · filed 2018-02-28 | |||
| 2017-03-31 | 191.00K shares 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | 347.00K shares 10-K · filed 2018-02-28 | |||
| 2016-03-31 | 297.00K shares 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | 773.00K shares 10-K · filed 2018-02-28 | |||
| 2015-03-31 | 767.00K shares 10-Q · filed 2015-05-08 | |||
| 2014-12-31 | 1.20M shares 10-K · filed 2017-03-14 | |||
| 2014-03-31 | 1.17M shares 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | 984.00K shares 10-K · filed 2016-03-14 | |||
| 2013-03-31 | 900.00K shares 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | 783.00K shares 10-K · filed 2015-03-12 | |||
| 2012-06-30 | 750.69K shares 10-Q · filed 2012-08-08 | |||
| 2011-12-31 | 1.14M shares 10-K · filed 2014-03-14 | |||
| 2010-12-31 | 709.00K shares 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |